Clinical data sets
RCOphth datasets recommending the variables to be collected and standardisation of data content, meaning and format for electronic use. Once approved, EMR systems will need to conform to this standard.
Our range of high-quality guidance helps to maintain standards in the planning, practice and commissioning of patient care. Our clinical guidelines provide evidence-based recommendations across all aspect of care or of eye conditions; Concise Practice Points make recommendations for less frequent and targeted clinical situations, succinctly describing the scientific and clinical evidence alongside expert input to enhance clinician and patient decision making. Our Commissioning guidance supports eye units to develop services to meet local population needs.
RCOphth datasets recommending the variables to be collected and standardisation of data content, meaning and format for electronic use. Once approved, EMR systems will need to conform to this standard.
A guideline to help ophthalmologists be familiar with clinical presentation, the differential diagnosis and controversies associated with attributing the presence or absence of retinal findings to abusive head injury in children.
A guideline to help ophthalmologists be familiar with clinical presentation, the differential diagnosis and controversies associated with attributing the presence or absence of retinal findings to abusive head injury in children.
Cerebral Visual Impairment is the commonest cause of visual impairment in children in the developed nations. It is a common condition which every ophthalmologist may expect to encounter in a paediatric ophthalmology clinic. This CVI CPP focuses on relevant questions drawn from roundtable discussions with orthoptists, optometrists, ophthalmologists, parents, teachers of the visually impaired and third sector organisations. It represents current understanding of the topic and acknowledges the evolving nature of practice. It will be regularly reviewed in the light of emerging evidence.
Summarises the referral pathway for children who fail vision screening aged 4 to 5 years as part of the childhood vision screening programme.
A single point of reference for busy clinicians when managing these complex patients from differential diagnosis, through long-term management, to discharge. It also covers provision of support for patients and carers throughout and beyond clinical care pathways.
This guideline covers the screening and treatment of reinopathy of prematurity. Retinopathy of prematurity (ROP) is a potentially blinding condition affecting low gestation and very low birth weight infants. Worldwide it is a major cause of preventable blindness. Screening for ROP is undertaken to identify ROP that requires treatment. This evidence-based guideline for the treatment of ROP was developed by a guideline development group (GDG) of The Royal College of Ophthalmologists (RCOphth), the UK special interest group of ROP screeners and treaters (ROP-SIG) and the charity Bliss. The guideline was produced according to RCOphth standards for guideline development.
This paper produced by SeeAbility, the Association of British Dispensing Opticians, the British and Irish Orthoptic Society, the College of Optometrists, the Local Optical Committee Support Unit (LOCSU) and the Royal College of Ophthalmologists, supported with advice from the Children’s Vision Service Advisory Group in Wales, provides a framework whereby all children and young people in special schools in England gain equitable access to regular eye care
This document represents the expert consensus, based on available evidence and national guidance, of the Paediatric Sub-committee of The Royal College of Ophthalmologists (RCOphth) regarding best practice and fundamental standards for children’s ophthalmic services.